Jinming Han
Allen Institute for Brain Science
ORCID: 0000-0002-6084-3275Also affiliated with Beijing Institute of Education, Shandong University, Center for Orthopaedics, Qilu Hospital of Shandong University, Ningbo No.6 Hospital
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 2 papers. Top paper: “Feasibility and tolerability of sintilimab plus anlotinib as the second‐line therapy for patients with advanced biliary tract cancers: An open‐label, single‐arm, phase II clinical trial”.
Ruihua Zhao, Chuang Zhou, Qian Zhong, Jianxiang Shi, Chang Su +21 more
Zhehao Zhang, Linlin Gao, Guang Jin, Lijun Guo, Yudong Yao +3 more